State Street SPDR S&P Biotech ETFXBI
Closing prices as of Oct 5, 2026Updated once daily after the US close — not a live quote.

$156.36

-4.36% past month

Notable price movement

  • Oct 5, 2026

    $156.19+1.14%

  • Oct 2, 2026

    $154.43-0.05%

  • Oct 1, 2026

    $154.51-2.01%

    The shares fell 2.01% while the broad market, measured by the S&P 500 ETF (SPY), rose 0.18% on the same session . The decline was therefore not shared by the broad market .

  • Sep 30, 2026

    $157.68+0.55%

  • Sep 29, 2026

    $156.81+0.13%

  • Sep 28, 2026

    $156.61+1.02%

  • Sep 25, 2026

    $155.03-0.65%

Closing prices for XBI. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Recent news

Seeking Alpha1 day agoWhat's next for personalized mRNA cancer vaccines?The Motley Fool1 day agoBetter Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting BiotechEtf TrendsJul 17, 2026Healthcare Rules State Street’s Top 5 ETFs in Past MonthSeeking Alpha2 days agoSA Asks: Is Moderna's stock now a sell after the recent run-up?The Motley Fool2 days agoBetter State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting PharmaceuticalsSeeking Alpha4 days agoEquity Outlook: AI, Higher Rates Raise The Bar For Diversification

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.

Prices and financial data are historical and provided for research only. Not investment advice.